Literature DB >> 16135403

Caveolin isoform expression during differentiation of C6 glioma cells.

W I Silva1, H M Maldonado, G Velázquez, M Rubio-Dávila, J D Miranda, E Aquino, N Mayol, A Cruz-Torres, J Jardón, I K Salgado-Villanueva.   

Abstract

Caveolae, a specialized form of lipid rafts, are cholesterol- and sphingolipid-rich membrane microdomains implicated in potocytosis, endocytosis, transcytosis, and as platforms for signal transduction. One of the major constituents of caveolae are three highly homologous caveolin isoforms (caveolin-1, caveolin-2, and caveolin-3). The present study expands the analysis of caveolin isoform expression in C6 glioma cells. Three complementary approaches were used to assess their differential expression during the dibutyryl-cyclic AMP-induced differentiation of C6 cells into an astrocyte-like phenotype. Immunoblotting, conventional RT-PCR, and real-time RT-PCR analysis established the expression of the caveolin-3 isoform in C6 cells, in addition to caveolin-1 and caveolin-2. Similar to the other isoforms, caveolin-3 was associated with light-density, detergent-insoluble caveolae membrane fractions obtained using sucrose-density gradient centrifugation. The three caveolin isoforms display different temporal patterns of mRNA/protein expression during the differentiation of C6 cells. Western blot and real-time RT-PCR analysis demonstrate that caveolin-1 and caveolin-2 are up-regulated during the late stages of the differentiation of C6 cells. Meanwhile, caveolin-3 is gradually down-regulated during the differentiation process. Indirect immunofluorescence analysis via laser-scanning confocal microscopy reveals that the three caveolin isoforms display similar subcellular distribution patterns. In addition, co-localization of caveolin-1/caveolin-2 and caveolin-1/caveolin-3 was detected in both C6 glioma phenotypes. The findings reveal a differential temporal pattern of caveolin gene expression during phenotypic differentiation of C6 glioma cells, with potential implications to developmental and degenerative events in the brain.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16135403     DOI: 10.1016/j.ijdevneu.2005.07.007

Source DB:  PubMed          Journal:  Int J Dev Neurosci        ISSN: 0736-5748            Impact factor:   2.540


  16 in total

1.  SorLA in glia: shared subcellular distribution patterns with caveolin-1.

Authors:  Iris K Salgado; Melissa Serrano; José O García; Namyr A Martínez; Héctor M Maldonado; Carlos A Báez-Pagán; José A Lasalde-Dominicci; Walter I Silva
Journal:  Cell Mol Neurobiol       Date:  2011-11-30       Impact factor: 5.046

2.  Expression profile of flotillin-2 and its pathophysiological role after spinal cord injury.

Authors:  José M Santiago; Aranza I Torrado; Luz C Arocho; Odrick R Rosas; Ana E Rodríguez; Franchesca König Toro; Iris K Salgado; Yaría Arroyo Torres; Walter I Silva; Jorge D Miranda
Journal:  J Mol Neurosci       Date:  2012-08-10       Impact factor: 3.444

3.  Caveolin-1: an essential modulator of cancer cell radio-and chemoresistance.

Authors:  Stephanie Hehlgans; Nils Cordes
Journal:  Am J Cancer Res       Date:  2011-03-20       Impact factor: 6.166

4.  P2Y2 receptor expression is altered in rats after spinal cord injury.

Authors:  Ana E Rodríguez-Zayas; Aranza I Torrado; Jorge D Miranda
Journal:  Int J Dev Neurosci       Date:  2010-07-07       Impact factor: 2.457

5.  Temozolomide modifies caveolin-1 expression in experimental malignant gliomas in vitro and in vivo.

Authors:  Céline Bruyère; Laurence Abeloos; Delphine Lamoral-Theys; Rebecca Senetta; Véronique Mathieu; Marie Le Mercier; Richard E Kast; Paola Cassoni; Guy Vandenbussche; Robert Kiss; Florence Lefranc
Journal:  Transl Oncol       Date:  2011-04-01       Impact factor: 4.243

6.  Mechanisms of the increase in the permeability of the blood-tumor barrier obtained by combining low-frequency ultrasound irradiation with small-dose bradykinin.

Authors:  Chun-yi Xia; Zhen Zhang; Yi-xue Xue; Ping Wang; Yun-hui Liu
Journal:  J Neurooncol       Date:  2009-02-22       Impact factor: 4.130

7.  Endothelial cells isolated from caveolin-2 knockout mice display higher proliferation rate and cell cycle progression relative to their wild-type counterparts.

Authors:  Leike Xie; Philippe G Frank; Michael P Lisanti; Grzegorz Sowa
Journal:  Am J Physiol Cell Physiol       Date:  2009-12-09       Impact factor: 4.249

8.  Are Synchronized Changes in Connexin-43 and Caveolin-3 a Bystander Effect in a Phoneutria nigriventer Venom Model of Blood-Brain Barrier Breakdown?

Authors:  Edilene Siqueira Soares; Monique Culturato Padilha Mendonça; Thalita Rocha; Evanguedes Kalapothakis; Maria Alice da Cruz-Höfling
Journal:  J Mol Neurosci       Date:  2016-04-11       Impact factor: 3.444

9.  Caveolin-1 Regulates the P2Y2 Receptor Signaling in Human 1321N1 Astrocytoma Cells.

Authors:  Namyr A Martinez; Alondra M Ayala; Magdiel Martinez; Freddyson J Martinez-Rivera; Jorge D Miranda; Walter I Silva
Journal:  J Biol Chem       Date:  2016-04-18       Impact factor: 5.157

10.  Differential cell-specific location of Cav-1 and Ca(2+)-ATPase in terminal Schwann cells and mechanoreceptive Ruffini endings in the periodontal ligament of the rat incisor.

Authors:  Naoyuki Iizuka; Akiko Suzuki; Kayoko Nozawa-Inoue; Yoshiro Kawano; B G T L Nandasena; Takashi Okiji; Takeyasu Maeda
Journal:  J Anat       Date:  2009-02       Impact factor: 2.610

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.